Hong Kong stock unusual | Lai Kai Medicine-B (02105.HK) rose more than 5% in early trading, LAE002 is expected to submit NDA in the first half of 2026.

According to the Wisdom FinTech app, Lai Kai Medicine-B (02105.HK) surged by more than 5% in the morning session. As of the time of writing, it has increased by 5.63% to HK$16.9, with a turnover of HK$28.6972 million.